Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

α1-Heavy Chain Deposition Disease With Negative Immunofluorescence Staining on Renal Biopsy.

Best Rocha A, Larsen CP, Delyria PA, Polavaram LS, Said SM, Shibata RS, Rech KL, Nasr SH.

Kidney Int Rep. 2018 Sep 18;4(1):178-183. doi: 10.1016/j.ekir.2018.09.007. eCollection 2019 Jan. No abstract available.

2.

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0102-7.

PMID:
30568288
3.

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4. Review. Erratum in: Nat Rev Nephrol. 2018 Dec 19;:.

PMID:
30510265
4.

Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy
.

Sathick IJ, Zand L, Nasr SH, Leung N.

Clin Nephrol. 2019 Feb;91(2):79-86. doi: 10.5414/CN109442.

PMID:
30474593
5.

Paraffin Immunofluorescence: A Valuable Ancillary Technique in Renal Pathology.

Nasr SH, Fidler ME, Said SM.

Kidney Int Rep. 2018 Jul 7;3(6):1260-1266. doi: 10.1016/j.ekir.2018.07.008. eCollection 2018 Nov. Review.

6.

CKD Due to a Novel Mitochondrial DNA Mutation: A Case Report.

Fervenza FC, Gavrilova RH, Nasr SH, Irazabal MV, Nath KA.

Am J Kidney Dis. 2018 Oct 8. pii: S0272-6386(18)30840-0. doi: 10.1053/j.ajkd.2018.06.032. [Epub ahead of print]

PMID:
30309714
7.

Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation.

Sethi S, Dasari S, Plaisier E, Ronco P, Nasr SH, Brocheriou I, Theis JD, Vrana JA, Zimmermann MT, Quint PS, McPhail ED, Kurtin PJ.

Kidney Int Rep. 2018 Apr 22;3(5):1193-1201. doi: 10.1016/j.ekir.2018.04.009. eCollection 2018 Sep.

8.

Congophilic Fibrillary Glomerulonephritis: A Case Series.

Alexander MP, Dasari S, Vrana JA, Riopel J, Valeri AM, Markowitz GS, Hever A, Bijol V, Larsen CP, Cornell LD, Fidler ME, Said SM, Sethi S, Herrera Hernandez LP, Grande JP, Erickson SB, Fervenza FC, Leung N, Kurtin PJ, Nasr SH.

Am J Kidney Dis. 2018 Sep;72(3):325-336. doi: 10.1053/j.ajkd.2018.03.017. Epub 2018 Jun 14.

PMID:
29866458
9.

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.

Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1037-1046. doi: 10.2215/CJN.13041117. Epub 2018 May 30.

PMID:
29848505
10.

Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.

Manohar S, Nasr SH, Leung N.

Curr Hematol Malig Rep. 2018 Jun;13(3):220-226. doi: 10.1007/s11899-018-0451-0. Review.

PMID:
29725932
11.

Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft.

Said SM, Cosio FG, Valeri AM, Leung N, Sethi S, Salameh H, Cornell LD, Fidler ME, Alexander MP, Fervenza FC, Drosou ME, Zhang D, D'Agati VD, Nasr SH.

Kidney Int. 2018 Jul;94(1):159-169. doi: 10.1016/j.kint.2018.01.028. Epub 2018 Apr 30.

PMID:
29716794
12.

MiRNA extraction from cell-free biofluid using protein corona formed around carboxyl magnetic nanoparticles.

Xu S, Nasr SH, Chen D, Zhang X, Sun L, Huang X, Qian C.

ACS Biomater Sci Eng. 2018 Feb 12;4(2):654-662. doi: 10.1021/acsbiomaterials.7b00668. Epub 2017 Dec 18.

13.

DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis.

Nasr SH, Vrana JA, Dasari S, Bridoux F, Fidler ME, Kaaki S, Quellard N, Rinsant A, Goujon JM, Sethi S, Fervenza FC, Cornell LD, Said SM, McPhail ED, Herrera Hernandez LP, Grande JP, Hogan MC, Lieske JC, Leung N, Kurtin PJ, Alexander MP.

Kidney Int Rep. 2017 Aug 8;3(1):56-64. doi: 10.1016/j.ekir.2017.07.017. eCollection 2018 Jan.

14.

Proliferative Glomerulonephritis With Masked Monoclonal Deposits Responsive to Myeloma Therapy.

Howlader A, Thajudeen B, Sussman AN, Bracamonte E, Krahl L, Nasr SH.

Kidney Int Rep. 2017 May 5;2(6):1233-1237. doi: 10.1016/j.ekir.2017.05.001. eCollection 2017 Nov. No abstract available.

15.

Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease.

Sekulic M, Nasr SH, Grande JP, Cornell LD.

Clin Kidney J. 2017 Dec;10(6):738-741. doi: 10.1093/ckj/sfx045. Epub 2017 Jun 5.

16.

Dense deposit disease associated with multiple myeloma
.

Alkhunaizi AM, AlKhatti AA, Nasr SH, Alexander MP.

Clin Nephrol. 2018 Apr;89(4):300-304. doi: 10.5414/CN109308.

PMID:
29208205
17.

Clinical Manifestations and Outcomes of Fluoroquinolone-Related Acute Interstitial Nephritis.

Farid S, Mahmood M, Abu Saleh OM, Hamadah A, Nasr SH, Garrigos ZE, Leung N, Sohail MR.

Mayo Clin Proc. 2018 Jan;93(1):25-31. doi: 10.1016/j.mayocp.2017.08.024. Epub 2017 Nov 20.

PMID:
29157532
18.

Urinalysis for the diagnosis of glomerulonephritis: role of dysmorphic red blood cells.

Hamadah AM, Gharaibeh K, Mara KC, Thompson KA, Lieske JC, Said S, Nasr SH, Leung N.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1397-1403. doi: 10.1093/ndt/gfx274.

PMID:
29156008
19.

Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.

Nasr SH, Kouyoumdjian H, Mallett C, Ramadan S, Zhu DC, Shapiro EM, Huang X.

Small. 2018 Jan;14(3). doi: 10.1002/smll.201701828. Epub 2017 Nov 14.

20.

Dysproteinemias and Glomerular Disease.

Leung N, Drosou ME, Nasr SH.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):128-139. doi: 10.2215/CJN.00560117. Epub 2017 Nov 7.

21.

DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN.

Dasari S, Alexander MP, Vrana JA, Theis JD, Mills JR, Negron V, Sethi S, Dispenzieri A, Highsmith WE Jr, Nasr SH, Kurtin PJ.

J Am Soc Nephrol. 2018 Jan;29(1):51-56. doi: 10.1681/ASN.2017030306. Epub 2017 Nov 2.

22.

Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.

Ramirez-Alvarado M, Barnidge DR, Murray DL, Dispenzieri A, Marin-Argany M, Dick CJ, Cooper SA, Nasr SH, Ward CJ, Dasari S, Jiménez-Zepeda VH, Leung N.

Am J Hematol. 2017 Jun;92(6):536-541. doi: 10.1002/ajh.24717. Epub 2017 May 4.

23.

Detection of ALECT2 amyloidosis by positron emission tomography-computed tomography imaging with florbetapir.

Leung N, Ramirez-Alvarado M, Nasr SH, Kemp BJ, Johnson GB.

Br J Haematol. 2017 Apr;177(1):12. doi: 10.1111/bjh.14519. Epub 2017 Jan 20. No abstract available.

PMID:
28107549
24.

Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype.

Nasr SH, Dasari S, Mills JR, Theis JD, Zimmermann MT, Fonseca R, Vrana JA, Lester SJ, McLaughlin BM, Gillespie R, Highsmith WE Jr, Lee JJ, Dispenzieri A, Kurtin PJ.

J Am Soc Nephrol. 2017 Feb;28(2):431-438. doi: 10.1681/ASN.2016090951. Epub 2017 Jan 3.

25.

Outcomes of patients with renal monoclonal immunoglobulin deposition disease.

Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N.

Am J Hematol. 2016 Nov;91(11):1123-1128. doi: 10.1002/ajh.24528. Epub 2016 Aug 29.

26.

Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome.

Said SM, Fidler ME, Valeri AM, McCann B, Fiedler W, Cornell LD, Alexander MP, Alkhunaizi AM, Sullivan A, Cramer CH, Hogan MC, Nasr SH.

Kidney Int Rep. 2016 Sep 29;2(1):44-52. doi: 10.1016/j.ekir.2016.09.056. eCollection 2017 Jan.

27.

Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.

Bonsib SM, Boils C, Gokden N, Grignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C, Sangoi AR, Wilson J, Zhang PL.

Pathol Res Pract. 2016 Nov;212(11):972-979. doi: 10.1016/j.prp.2016.04.005. Epub 2016 Apr 30.

28.

Silent diabetic nephropathy.

Said SM, Nasr SH.

Kidney Int. 2016 Jul;90(1):24-6. doi: 10.1016/j.kint.2016.02.042.

PMID:
27312444
29.

Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.

Nasr SH, Dasari S, Hasadsri L, Theis JD, Vrana JA, Gertz MA, Muppa P, Zimmermann MT, Grogg KL, Dispenzieri A, Sethi S, Highsmith WE Jr, Merlini G, Leung N, Kurtin PJ.

J Am Soc Nephrol. 2017 Feb;28(2):439-445. doi: 10.1681/ASN.2015111228. Epub 2016 Jun 13.

30.

Proteasome inhibitor associated thrombotic microangiopathy.

Yui JC, Van Keer J, Weiss BM, Waxman AJ, Palmer MB, D'Agati VD, Kastritis E, Dimopoulos MA, Vij R, Bansal D, Dingli D, Nasr SH, Leung N.

Am J Hematol. 2016 Sep;91(9):E348-52. doi: 10.1002/ajh.24447. Epub 2016 Jul 4.

31.

Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.

Dasari S, Amin MS, Kurtin PJ, Vrana JA, Theis JD, Grogg KL, Alexander MP, Nasr SH, Fervenza FC, Leung N, Sethi S.

Kidney Int. 2016 Sep;90(3):658-64. doi: 10.1016/j.kint.2016.04.003. Epub 2016 Jun 2.

PMID:
27262366
32.

The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis.

Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, Sethi S, Leung N, Fervenza FC, Cornell LD.

Kidney Int. 2016 Apr;89(4):897-908. doi: 10.1016/j.kint.2016.02.001.

PMID:
26994577
33.

A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.

Leung N, Nasr SH.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1073-82. doi: 10.2215/CJN.10641015. Epub 2016 Mar 18.

34.

Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians.

Larsen CP, Ismail W, Kurtin PJ, Vrana JA, Dasari S, Nasr SH.

Mod Pathol. 2016 Apr;29(4):416-20. doi: 10.1038/modpathol.2016.29. Epub 2016 Feb 12.

35.

Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis.

Cheungpasitporn W, Zacharek CC, Fervenza FC, Cornell LD, Sethi S, Herrera Hernandez LP, Nasr SH, Alexander MP.

Clin Kidney J. 2016 Feb;9(1):97-101. doi: 10.1093/ckj/sfv126. Epub 2015 Nov 30.

36.

Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.

Ali A, Schlanger L, Nasr SH, Sethi S, Gorbatkin SM.

Am J Kidney Dis. 2016 Mar;67(3):479-82. doi: 10.1053/j.ajkd.2015.10.020. Epub 2015 Dec 17.

PMID:
26704376
37.

Acute bile nephropathy secondary to anabolic steroids.

Alkhunaizi AM, ElTigani MA, Rabah RS, Nasr SH.

Clin Nephrol. 2016 Feb;85(2):121-6. doi: 10.5414/CN108696.

PMID:
26587777
38.

Renal extramedullary hematopoiesis: interstitial and glomerular pathology.

Alexander MP, Nasr SH, Kurtin PJ, Casey ET, Hernandez LP, Fidler ME, Sethi S, Cornell LD.

Mod Pathol. 2015 Dec;28(12):1574-83. doi: 10.1038/modpathol.2015.117. Epub 2015 Oct 9.

39.

C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?

Alexander MP, Fervenza FC, De Vriese AS, Smith RJH, Nasr SH, Cornell LD, Herrera Hernandez LP, Zhang Y, Sethi S.

J Nephrol. 2016 Apr;29(2):203-209. doi: 10.1007/s40620-015-0218-9. Epub 2015 Jul 18.

PMID:
26187133
40.

Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.

Larsen CP, Messias NC, Walker PD, Fidler ME, Cornell LD, Hernandez LH, Alexander MP, Sethi S, Nasr SH.

Kidney Int. 2015 Oct;88(4):867-73. doi: 10.1038/ki.2015.195. Epub 2015 Jul 8.

41.

The Authors Reply.

Bridoux F, Leung N, Fermand JP, Touchard G, Nasr SH.

Kidney Int. 2015 Jul;88(1):202. doi: 10.1038/ki.2015.136. No abstract available.

PMID:
26126104
42.

Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience.

Strati P, Nasr SH, Leung N, Hanson CA, Chaffee KG, Schwager SM, Achenbach SJ, Call TG, Parikh SA, Ding W, Kay NE, Shanafelt TD.

Haematologica. 2015 Sep;100(9):1180-8. doi: 10.3324/haematol.2015.128793. Epub 2015 Jun 18.

43.

C4d as a Diagnostic Tool in Proliferative GN.

Sethi S, Nasr SH, De Vriese AS, Fervenza FC.

J Am Soc Nephrol. 2015 Nov;26(11):2852-9. doi: 10.1681/ASN.2014040406. Epub 2015 May 19.

44.

Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits.

Bhutani G, Nasr SH, Said SM, Sethi S, Fervenza FC, Morice WG, Kurtin PJ, Buadi FK, Dingli D, Dispenzieri A, Gertz MA, Lacy MQ, Kapoor P, Kumar S, Kyle RA, Rajkumar SV, Leung N.

Mayo Clin Proc. 2015 May;90(5):587-96. doi: 10.1016/j.mayocp.2015.01.024.

PMID:
25939936
45.

Quiz page May 2015: crystalline nephropathy in an identical twin.

Agrawal V, Gibson PC, Sahota A, Nasr SH.

Am J Kidney Dis. 2015 May;65(5):A17-9. doi: 10.1053/j.ajkd.2014.12.019. No abstract available.

46.

Intravitreal Antivascular Endothelial Growth Factor Therapy May Induce Proteinuria and Antibody Mediated Injury in Renal Allografts.

Cheungpasitporn W, Chebib FT, Cornell LD, Brodin ML, Nasr SH, Schinstock CA, Stegall MD, Amer H.

Transplantation. 2015 Nov;99(11):2382-6. doi: 10.1097/TP.0000000000000750.

PMID:
25905984
47.

Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics.

Nasr SH, Dogan A, Larsen CP.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2084-93. doi: 10.2215/CJN.12551214. Epub 2015 Apr 14. Review.

48.

Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.

Zand L, Nasr SH, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Kumar S, Kyle RA, Fervenza FC, Sethi S, Dingli D, Rajkumar SV, Kapoor P, McCurdy A, Leung N.

Leuk Lymphoma. 2015;56(12):3357-64. doi: 10.3109/10428194.2015.1040011. Epub 2015 May 12.

PMID:
25860232
49.

Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.

Safadi S, Saad A, Quint PS, Sethi S, Leung N, Kurtin P, Nasr SH.

Nephrol Dial Transplant. 2015 Jul;30(7):1151-5. doi: 10.1093/ndt/gfv018. Epub 2015 Mar 21.

PMID:
25796445
50.

Granulomatous interstitial nephritis secondary to chronic lymphocytic leukemia/small lymphocytic lymphoma.

Nasr SH, Shanafelt TD, Hanson CA, Fidler ME, Cornell LD, Sethi S, Chaffee KG, Morris J, Leung N.

Ann Diagn Pathol. 2015 Jun;19(3):130-6. doi: 10.1016/j.anndiagpath.2015.03.003. Epub 2015 Mar 6.

PMID:
25795422

Supplemental Content

Support Center